Dr. Andrew Farach, MD
What this data tells you about Dr. Farach
Dr. Andrew Farach is a radiology - diagnostic in Houston, TX, with 10 years in practice. Based on federal Medicare data, Dr. Farach performed 2,827 Medicare services across 1,130 unique beneficiaries.
Between the years covered by Open Payments, Dr. Farach received a total of $24,151 from 18 pharmaceutical and/or device companies across 70 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Farach is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| CT guidance for radiation therapy | 1,029 | $35 | $165 |
| Calculation of radiation therapy dose | 425 | $26 | $172 |
| Radiation treatment management, 5 treatment sessions | 234 | $153 | $1,000 |
| Design and construction of complex radiation treatment device | 141 | $48 | $321 |
| Design and construction of radiation treatment device for high precision radiation therapy | 122 | $179 | $1,187 |
| High precision radiation therapy planning | 119 | $328 | $2,210 |
| Complex radiation therapy planning | 85 | $128 | $844 |
| Special radiation treatment | 82 | $83 | $566 |
| Office visit, established patient (20-29 min) | 67 | $50 | $151 |
| New patient office visit, complex (60-74 min) | 59 | $140 | $492 |
| Office visit, established patient (30-39 min) | 49 | $77 | $230 |
| Obtaining respiratory data needed to develop the optimal radiation treatment | 45 | $81 | $558 |
| Ultrasonic guidance for needle placement | 34 | $25 | $122 |
| Management of cranial lesion surgery using radiation over multiple sessions | 33 | $501 | $3,376 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 30 | $31 | $197 |
| High dose radiation therapy, more than 12 channels | 29 | $228 | $1,486 |
| Insertion of needle or tube into prostate for radiation therapy | 28 | $629 | $4,015 |
| High dose radiation therapy, 2-12 channels | 26 | $160 | $1,051 |
| Placement of device in prostate for radiation therapy | 24 | $39 | $580 |
| 3d radiation therapy planning | 24 | $179 | $1,187 |
| Office visit, established patient, complex (40-54 min) | 24 | $115 | $323 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 23 | $61 | $435 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 23 | $17 | $107 |
| High dose radiation therapy, 1 channel | 19 | $80 | $542 |
| Injection of biodegradable material next to prostate | 18 | $73 | $875 |
| Design and construction of simple radiation treatment device | 18 | $19 | $125 |
| Initial hospital admission, moderate complexity | 17 | $105 | $401 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in radiology - diagnostic and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for radiology - diagnostic in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Farach is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 7%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Farach experienced with ct guidance for radiation therapy?
Does Dr. Farach receive payments from pharmaceutical companies?
How do Dr. Farach's costs compare to other radiology - diagnostics in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology